v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Cash flows from operating activities      
Net income (loss) $ 5,023 $ (24,436)  
Adjustments for:      
Share-based compensation expense 9,489 8,964  
Depreciation 854 1,011  
Unrealized foreign exchange (gains) losses, net (2,907) 1,304  
Unrealized gains on marketable securities (5,469) 0 $ (14,600)
Non-cash lease expense 546 432  
Other 509 (2)  
Changes in assets and liabilities:      
Decrease (increase) in accounts receivable 836 (6,198)  
Increase in prepayments and other current assets (28) (1,819)  
Increase (decrease) in accounts payable 3,342 (2,320)  
(Decrease) increase in accrued expenses (10,943) 19,169  
Increase (decrease) in operating lease liabilities 756 (490)  
Increase in other operating assets (1,573) (1,395)  
Increase in other operating liabilities 0 1,193  
Net cash provided by (used in) operating activities 435 (4,587)  
Cash flows from investing activities      
Proceeds from sale of marketable securities 10,000 0  
Purchase of property and equipment (298) (430)  
Net cash provided by (used in) investing activities 9,702 (430)  
Cash flows from financing activities      
Proceeds from exercise of share options 2,551 5,754  
Proceeds from issue of convertible loan notes 0 402,500  
Payments for debt issuance costs 0 (12,242)  
Net cash provided by financing activities 2,551 396,012  
Increase in net cash and cash equivalents 12,688 390,995  
Net foreign exchange difference on cash held 8,426 (800)  
Cash and cash equivalents at beginning of period 455,731 442,626 442,626
Cash and cash equivalents at end of period 476,845 832,821 $ 455,731
Supplemental disclosure of cash flow and non-cash information      
Cash (paid) received for interest, net (5,031) 5,141  
Cash paid for income taxes, net (32) (140)  
Debt issuance costs in accrued expenses and other current liabilities $ 0 $ (1,116)